Objective:

To summarize key insights and developments presented at the ASRS annual meeting, focusing on ocular oncology, pediatric retina, and uveitis treatments, while also reflecting on the networking and educational opportunities available.

Key Findings:

• Timely diagnosis is crucial for preventing vision loss in ocular tumors, as emphasized by multiple speakers.
• AI can enhance the diagnosis and monitoring of retinopathy of prematurity, potentially changing standard practices.
• IL-6 inhibitors are a promising area of research for treating noninfectious uveitis, with ongoing studies discussed.
• The PDS for ranibizumab presents both efficacy and safety challenges, as highlighted in the controversies session.

Interpretation:

The ASRS meeting highlighted significant advancements in retinal care, emphasizing the integration of new technologies and treatment strategies, and their implications for clinical practice.

Limitations:

• Not all retinal topics could be covered due to time constraints at the conference, including emerging therapies and techniques.
• The adoption of new technologies like the PDS may face practical challenges, including safety concerns and clinician training.

Conclusion:

The ASRS meeting reinforced the importance of continuous education and collaboration within the retina community to enhance patient care.